ALXO

ALX Oncology Holdings Inc. Common Stock

$1.80 -5.26%

Recent alerts on ALXO

All signals →

News Mesoblast (MESO) Soars 208% YTD on Positive Regulatory Updates

News Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag

News Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates - Zacks Investment Research

News CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business

News Novo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal

News Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug

News Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

News Cogent (COGT) Up on SUMMIT Study Update Post Positive FDA Meeting

News AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection

News Bayer's (BAYRY) AskBio Advances Parkinson Disease Study

News Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe

News Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

News Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals

News Novo Nordisk (NVO) to Invest $4.1B in Clayton Facility Expansion

News Roche's (RHHBY) Ocrevus Subcutaneous Gets European Commission Nod

News JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals

News Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection

News Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies

News Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals

News Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals

News Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up

News Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics

News Shattuck (STTK) Announces Positive Interim Data on Cancer Drug

News Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro

News Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study

Get push alerts for ALXO

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS